September 20, 2014 9:05 AM ET

Capital Markets

Company Overview of Truffle Capital

Company Overview

Truffle Capital is a venture capital and private equity firm specializing in startup, post start up, growth capital, investments in spins offs from initial round to the pre-exit round, LBOs, and PIPEs. The firm invests in information technology, energy, life sciences, telecommunication, electronics, and biotechnology and pharmaceuticals. In information technology, it focuses on mobile content and connectivity, Internet, technical software, IT security, VOIP, and security and technical software. Within energy, the firm typically invests in energy efficiency, energy management, new technologies for traditional energies, and renewable energy like solar, wind, wave power, tidal power, mini-hydro...

5, rue de la Baume

Paris,  75008

France

Founded in 2001

Phone:

33 1 82 28 46 00

Fax:

33 1 47 20 12 09

Key Executives for Truffle Capital

Co-Founder
Age: 56
Chairman
Age: 76
Co-Founder
Age: 50
Chief Financial Officer and Chief Administrative Officer
Age: 60
Director of Operations and Risk Management
Compensation as of Fiscal Year 2014.

Truffle Capital Key Developments

Truffle Capital Announces Creation of ABIVAX in Collaboration with the Cuban Center for Genetic Engineering and Biotechnology

Truffle Capital has announced the creation of ABIVAX in collaboration with the Cuban Center for Genetic Engineering and Biotechnology (CIGB). This is the first ever start-up launched on the basis of a Euro-Cuban R&D collaboration. The goal of ABIVAX is to become a global leader in therapeutic vaccines and antivirals, leveraging both its existing product pipelines and future acquisitions that are currently in negotiations. ABIVAX specializes in therapeutic vaccines and antivirals, combining the technologies and the product portfolios of three French biotech companies financed by Truffle Capital (Wittycell, Splicos and Zophis). An exclusive partnership agreement with the CIGB has been approved by the Cuban government and will further enrich the portfolio. The CIGB is a subsidiary under BioCubaFarma that specializes in the discovery, development and production of vaccines and antivirals. ABIVAX already possesses several key assets including complementary technology platforms, a high-value product portfolio and an experienced top management team.

Similar Private Companies By Industry

Company Name Region
LR Conseil SARL Europe
FF&T Equity Europe
Carron & Cie SARL Europe
Girszyn & Associes Europe
ClickOptions Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
September 10, 2014
NetMediaEurope SA
Private Placement
July 9, 2014
Gènes' Ink
Merger/Acquisition
April 14, 2014
Rhapso S.A.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Truffle Capital, please visit www.truffle.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.